NCT04272632View on ClinicalTrials.gov

Coload Optimization Guided by Inferior Vena Cava Collapsibility Index

NACompletedINTERVENTIONAL
Enrollment

168

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

November 25, 2021

Study Completion Date

November 25, 2021

Conditions
Adverse Effect
Interventions
DRUG

4 ml/kg group

4 ml/kg compound sodium chloride (0.85% NaCl, 0.03% KCl, and 0.033% CaCl2) was given immediately after spinal anesthesia.

DRUG

8 ml/kg group

8 ml/kg compound sodium chloride (0.85% NaCl, 0.03% KCl, and 0.033% CaCl2) was given immediately after spinal anesthesia.

DRUG

12 ml/kg group

12 ml/kg compound sodium chloride (0.85% NaCl, 0.03% KCl, and 0.033% CaCl2) was given immediately after spinal anesthesia.

Trial Locations (1)

750004

General Hospital of Ningxia Medical University, Yinchuan

All Listed Sponsors
lead

General Hospital of Ningxia Medical University

OTHER

NCT04272632 - Coload Optimization Guided by Inferior Vena Cava Collapsibility Index | Biotech Hunter | Biotech Hunter